Preview: Lifecore Biomedical's Earnings
Portfolio Pulse from Benzinga Insights
Lifecore Biomedical (NASDAQ:LFCR) is set to release its latest quarterly earnings report on August 31, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. Shares are currently trading at $8.78 and have seen a 12.7% decrease over the last 52-week period.
August 30, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lifecore Biomedical is expected to report an EPS of $-0.37. The company's history of missing EPS estimates and subsequent share price drops may impact investor sentiment.
Given Lifecore Biomedical's history of missing EPS estimates and the subsequent negative impact on its share price, it is likely that the upcoming earnings report could have a negative impact on the stock. The estimated EPS of $-0.37, if not met or exceeded, could further decrease investor confidence and lead to a drop in the share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100